Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery

Verfasser / Beitragende:
[G. Zanetti, S. J. Goldie, R. Platt]
Ort, Verlag, Jahr:
2001
Enthalten in:
Emerging Infectious Diseases, 7/5(2001-10), 820-7
Format:
Artikel (online)
ID: 439481015